We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Brain Signal Discovered that Turns Off Fear

By Biotechdaily staff writers
Posted on 14 Nov 2002
A study has demonstrated that stimulating a site in the brain's prefrontal cortex extinguishes a fear response in rats. More...
The study was reported in the November 7, 2002, issue of Nature.

Normally, rats freeze with fear when hearing a tone they have been conditioned to associate with an electric shock. Researchers have detected a brain signal that when stimulated eliminates a fear response by mimicking the brain's own "safety signal.” They say this discovery could lead to new physiologic treatments for runaway fear responses such as those seen in anxiety disorders.

The researchers recorded electrical activity of neurons in the prefrontal cortex as rats were fear-conditioned. Then they abolished this conditioning by presenting the tone without the shock and the animals no longer froze when they heard the tone. Although inactive during both procedures, neurons near the middle of the prefrontal cortex fired conspicuously when the tone was sounded on the following day. This activity proved to be the brain's way of signaling that the tone no longer presaged a shock. The more the cells fired, the less the rats froze.

The researchers then electrically stimulated the infralimbic area in rats that had been fear conditioned but not extinguished--in effect simulating the safety signal, while pairing it with the tone. Remarkably, the rats showed little freezing. Later, the rats continued to be
unafraid of the tone even without the stimulation. The researchers propose that increased activity of infralimbic neurons in the prefrontal cortex strengthens memory of safety by inhibiting the amygdala's memory of fear. They speculate that stimulating parts of the prefrontal cortex in anxiety-disorder patients, using an experimental technique called transcranial magnetic stimulation, might help them control anxiety.

"Repeated exposure to traumatic reminders without any adverse consequences causes fear responses to gradually disappear,” explained Dr. Gregory Quirk, of the Ponce School of Medicine (Ponce, Puerto Rico), who led the research. "Such reduction of fear appears to be an active rather than passive process. It doesn't erase the fear association from memory, but generates a new memory for safety.” The research was funded by the US National Institute of Mental Health (NIMH)




Related Links:
National Institute of Mental Health (NIMH)

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.